Commitments and Contingencies (Details)			1 Months Ended		6 Months Ended
	Apr. 13, 2020 USD ($)	Sep. 03, 2014 USD ($) shares	Mar. 31, 2020 USD ($) $ / shares	Jan. 31, 2020 USD ($)	Jun. 30, 2020 USD ($) m²
Commitments and Contingencies (Details) [Line Items]
Commitments related to agreements					$ 450,000
Maximum payment for commitment milestones					$ 7,900,000
Percentage for royalties					6.00%
Office space (in Square Meters) | m²					6,200
Office rent amount					$ 11,883
Office rent amount, per square foot					23.00
Cash paid to acquire Hy Biopharma intangible asset		$ 275,000
Shares issued in connection with Hy BioPharma asset purchase agreement (in Shares) | shares		184,912
Fair value of shares issued in connection with Hy BioPharma asset purchase		$ 3,750,000	$ 1,956,182
Common stock price per share (in Dollars per share) | $ / shares			$ 2.56
Asset purchase agreement total expense			$ 5,000,000
Additional Payments					$ 5,000,000
ownership of the Company outstanding					19.90%
CARES Act Loan, description	the Company was advised that one of its principal banks, JPMorgan Chase Bank, N.A., had approved a $417,830 loan (the “Loan”) under the Paycheck Protection Program (“PPP”) pursuant to the Coronavirus Aid, Relief and Economic Security Act that was signed into law on March 27, 2020. As a U.S. small business, the Company qualified for the PPP, which allows businesses and nonprofits with fewer than 500 employees to obtain loans of up to $10 million to incentivize companies to maintain their workers as they manage the business disruptions caused by the COVID-19 pandemic. The PPP provides for loans for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The PPP loan proceeds may be used for eligible purposes, including payroll, benefits, rent and utilities.
Loan amount	$ 417,830
Paycheck Protection Program loan					$ 185,702
Paycheck Protection Program loan					232,128
Accrued interest expense					$ 682
Loan description					The Loan bears interest at a fixed rate of 0.98% per annum, with the first six months of interest and principal deferred. Some or all of the Loan may be forgiven if at least 75% of the Loan proceeds are used by the Company to cover payroll costs, including benefits and if the Company maintains its employment and compensation within certain parameters during the eight-week or twenty-four-week period following the Loan origination date and complies with other relevant conditions.
Minimum [Member]
Commitments and Contingencies (Details) [Line Items]
Authorized shares to be issued to Dr. Schaber immediately prior to the completion of a transaction				$ 5,000
Maximum [Member]
Commitments and Contingencies (Details) [Line Items]
Authorized shares to be issued to Dr. Schaber immediately prior to the completion of a transaction				$ 500,000